Rapid responses are electronic comments to the editor. They enable our users to debate issues raised in articles published on bmj.com. A rapid response is first posted online. If you need the URL (web address) of an individual response, simply click on the response headline and copy the URL from the browser window. A proportion of responses will, after editing, be published online and in the print journal as letters, which are indexed in PubMed. Rapid responses are not indexed in PubMed and they are not journal articles. The BMJ reserves the right to remove responses which are being wilfully misrepresented as published articles.
The issue of using dual antiplatelet therapy has an ever important presence while dealing with patients who have undergone PCI. These patients are usually at high risk of bleeding because of co morbidities and the added stresses of complex procedures. Additionally if these patients need any surgical intervention during 12 months post PCI.
Use of dual antiplatelets becomes clinically more challenging if patients are already on anticoagulants. The cited research will provide some much needed evidence base for clinicians when dealing with these situations. However providing strong case for changing current may require more extensive and inclusive work in the future.